We are live on
!
Find out more
IFA
Invus Financial Advisors Portfolio holdings
AUM
$89.2M
1-Year Est. Return
10.79%
This Fund
S&P 500
This Quarter
Est. Return
-2.04%
1 Year Est. Return
-10.79%
3 Year Est. Return
-29.46%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$208M
AUM Growth
-$68.8M
(-25%)
Cap. Flow
-$32.5M
Cap. Flow
% of AUM
-15.63%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
3
Closed
3
Top Buys
No buys this quarter
Top Sells
| 1 |
Yext
YEXT
|
+$14.6M |
| 2 |
NovoCure
NVCR
|
+$9.6M |
| 3 |
UBX
Unity Biotechnology
UBX
|
+$6.93M |
| 4 |
Chegg
CHGG
|
+$664K |
| 5 |
Sunrun
RUN
|
+$427K |
Sector Composition
| 1 | Healthcare | 76.04% |
| 2 | Technology | 23.96% |
| 3 | Consumer Discretionary | 0% |
| 4 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OYST
1
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $58.4M | 28.12% |
2,768,586
| – | – |
|
|
2
Yext
YEXT
$522M
| $49.8M | 23.96% |
3,280,885
-865,899
| -21% | -$14.6M |
|
|
3
NovoCure
NVCR
$1.86B
| $39.1M | 18.79% |
350,884
-120,000
| -25% | -$9.6M |
|
4
Arcus Biosciences
RCUS
$3.53B
| $31.6M | 15.19% |
1,842,077
| – | – |
|
5
Oric Pharmaceuticals
ORIC
$1.08B
| $25.2M | 12.12% |
1,007,576
| – | – |
|
|
UBX
6
DELISTED
Unity Biotechnology
UBX
| $3.79M | 1.82% |
109,500
-109,500
| -50% | -$6.93M |
|
7
Alibaba
BABA
$269B
| – | – |
-1,211
| Closed | -$261K |
|
|
8
Chegg
CHGG
$94.6M
| – | – |
-9,868
| Closed | -$664K |
|
|
9
Sunrun
RUN
$2.96B
| – | – |
-21,657
| Closed | -$427K |
|
Similar funds
ETIA
CC
OAMA
FWM
GIM
YSP
EL
CH